传感复合子结构与分子指纹结合,以预测药物向相互作用
Wanhua Huang1, Xuecong Tian1, Ying Su1
1School of Computer Science and Technology, Xinjiang University, Urumqi, 830046, China.
Interdisciplinary sciences, computational life sciences
|April 3, 2025
概括
这项研究引入了一个新的框架,通过整合分子子结构和多模式特征来预测药物向相互作用 (DTI). 该方法通过提高DTI预测准确度来增强药物发现和重新定位.
科学领域:
- 计算化学计算化学
- 药理学 药理学是指药理学的学科.
- 生物信息学是一种生物信息学.
背景情况:
- 准确识别药物向相互作用 (DTI) 对于药物发现和重新定位至关重要.
- 现有的DTI预测方法往往忽略了特定的分子亚结构信息,并且无法结合不同的特征学习方法.
- 这种限制导致在识别有效药物候选者的预测性能不足.
研究的目的:
- 提出一个新的框架,ASCS-DTI,用于增强药物向相互作用预测.
- 通过结合子结构信息和结合多个特征学习策略来解决现有方法的局限性.
- 提高DTI对药物发现和重新定位的预测的准确性和可靠性.
主要方法:
- 开发了ASCS-DTI框架,利用子结构注意力机制以捕获各种细节的关键子结构信息.
- 整合了三种不同的分子指纹方法,以实现全面的分子表示.
- 采用堆叠卷积编码模块,用于对目标蛋白序列信息的多层次处理.
- 实现了一个特征融合模块,用于分子图和指纹特征的多模式融合,以及DTI编码.
主要成果:
- 与基准数据集 (Biosnap,BindingDB,Human) 上的六种先进基线模型相比,ASCS-DTI框架显示出更高的性能.
- 在不同的实验环境中,在DTI预测准确度方面取得了显著的改进.
- 从化合物和全面的分子表示中有效地学习和利用重要的亚结构信息.
结论:
- 拟议的ASCS-DTI框架通过有效地整合子结构注意力和多模式特征学习,在DTI预测方面取得了重大进展.
- 这种方法增强了分子表示和蛋白质序列信息的表征,从而提高了预测性能.
- ASCS-DTI为加速药物发现和药物重新定位工作提供了一个强大的工具.
相关概念视频
Structure-Activity Relationships and Drug Design
420
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
420
Drug Discovery: Overview
7.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.1K
Drug-Receptor Bonds
2.6K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.6K
Targets for Drug Action: Overview
5.8K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
5.8K
Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Ligand Binding Sites
12.6K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.6K


